Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 59 min 10 sec ago

56% rise in GPs seeking mental health help in last year

As a results, NHS Practitioner Health plans to recruit around 40 additional clinicians and grow its therapist network.

BMS, Pfizer turn to Fitbit for atrial fibrillation detection

AFib is the most common type of irregular heartbeat and is a significant risk factor for stroke.

Xofluza bags FDA approval for flu complications

The drug is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from the flu.

CHMP U-turn for Evenity

The approval is for severe osteoporosis in postmenopausal women at high risk of fracture.

NICE ‘ok’ for Bayer’s Xarelto

The drug is an anticoagulant that targets Factor Xa, approved to prevent atherothrombotic events in coronary artery disease.

Clinigen launches programme to provide Azedra outside US

The Progenics drug is currently not approved for any indication outside of the US.

Chiesi announces two successful sets of asthma data

24% of asthma patients have difficult-to-treat or severe versions of the disease.

Genetic Parkinson’s cohorts ‘urgently’ need identifying

Only half of patients who are diagnosed as young onset patients are offered a genetic test on diagnosis.

Gov awards urgent meds freight contracts

UPS, DFDS and Biocair will handle express freight services to deliver medicines and medical products within 24 to 48 hours in the event of a no-deal Brexit.

AZ/Daiichi's breast cancer drug gets US priority review

AstraZeneca and Daiichi Sankyo's trastuzumab deruxtecan has taken a step closer to US approval having been accepted for priority review by the US Food and Drug Administration (FDA) for breast cancer.

Just two weeks left until MSEA closes for entry!

The 2019 Medical & Scientific Excellence Awards will be closing for entry on October 31.

Obesity levels of four and five-year-olds rose 9.5% last year

58,000 more children were recorded as obese than last year.

Ambulance staff to access patient mental health crisis plans

The system aims to help paramedics on the ground to make the right clinical decisions instead of taking the patient to A&E.

Investigational atopic dermatitis drug hits late-stage endpoints

There is currently a “critical need” for additional treatment options for atopic dermatitis.

Review recommends screening upgrade to save more lives

Professor Sir Mike Richards makes several recommendations, with a key focus on improving uptake.

Pfizer launches ‘catfish’ counterfeit medicines campaign

The campaign is aimed at students who don't know what they could be buying online.

FDA ‘yes’ for Eli Lilly’s Reyvow

The approval marks the first new class of acute migraine treatment approved by the FDA in more than two decades.

Survey reveals 'workforce crisis' in NHS

Performance statistics throughout the last year have shown “strain on an already stretched system."

Tailor-made drug shows success in Batten disease

The process could pave the way for more rapid delivery of individualised treatments.

Rituxan hits targets in late-stage pemphigus vulgaris trial

The study is still ongoing, with patients participating in a 48-week safety follow-up period.